Clinical cases, Clinical Trials

Lilly’s amyloid donanemab in Phase 2; how a neurologist approaches dementia in a man with memory, behavior problems: NEJM CPC 12.31.20

January 13, 2021 — 0 Comments

Research Administration, Research Strategy

Alz at $3B, “DREAM” of therapy?

January 5, 2021 — 0 Comments

Research Strategy

Hacking the brain? Reverse cognitive aging? Blood cells for nerve regeneration?

December 14, 2020 — 2 Comments

Clinical Trials, Research Strategy

Inflammaging & Fountain of Youth?

November 9, 2020 — 1 Comment

Research Strategy

The Marsh of your Mind: does sleep clean out your old abnormal proteins and prevent dementia[!?!]

October 29, 2020 — 0 Comments

Research Administration, Research Strategy

World Alzheimer’s Day 2020 today: new blood cancer therapies >60, Alzheimer drugs ZERO

September 21, 2020 — 0 Comments

Clinical Trials, Research Administration, Research Strategy

Dementia 2020: AAIC, ACT meetings, Lancet updated; no new real therapy, CELL and CTAD strategy papers

August 31, 2020 — 0 Comments

Clinical Trials, Research Strategy

Down Syndrome and Alzheimer’s; Drugs in the Pipeline 2020

July 27, 2020 — 0 Comments

Clinical Trials

Nasal insulin, baby aspirin disappoint; Can alcohol help? BP control, sleep

July 7, 2020 — 0 Comments

Clinical Trials, Research Strategy

The Feud, Tau vs. Amyloid, Act III?

May 26, 2020 — 0 Comments